Generic and over-the-counter drugs company Stada has asked the German government to seek assurances from Ukraine that the company can continue operations
there even though it also does business in Russia.
In a March 21 letter to German Economy Minister Robert Habeck, Stada CEO Peter Goldschmidt said there was a risk Kyiv might withdraw the company's market
authorisation.
Stada "still has no longer-term certainty that we will be able to sell our products in Ukraine in the future," the letter said, with the subject line: "Please
prevent the exclusion of international pharmaceutical companies from the Ukrainian market." The Economy Ministry did not have an immediate comment on the letter.
Habeck promised investment guarantees for German companies during a trip to Ukraine on Tuesday (April 4) as part of his goal to speed up reconstruction in the
war-torn country.
Goldschmidt said restricting Stada's operations would be bad for Ukraine.
The Medicines and Healthcare products Regulatory Agency (MHRA) has advised 'no one should stop taking valproate without advice from their healthcare
professional.'
The latest data on the use of valproate in England revealed that in the last 6 months the number of pregnant women prescribed valproate in a 6-month period has
fallen from 68 women in April to September 2018, to 17 women in October 2021 to March 2022.
In light of concerns that the current regulatory requirements for safe use are not being consistently followed, the MHRA conducted a review of the available data
and asked for advice from the independent Commission on Human Medicines (CHM).
"The CHM has advised that no one under the age of 55 should be initiated on valproate unless two specialists independently consider and document that there is no
other effective or tolerated treatment," said MHRA.
"Where possible, existing patients should be switched to another treatment unless two specialists independently consider and document that there is no other effective
or tolerated treatment or the risks do not apply."
After I have finished playing some casino games, using my, Juicy Stakes Casino bonuses, I am hungry. What should I eat? A juicy steak (wink, wink)? Fried
chicken? An Ingestible Pill? Wait, what? What is an ingestible pill? Is that a food or vitamin? Actually, it is neither.
It is new technology developed by Pfizer. Pfizer is the pharmaceutical company that gave us the COVID vaccines that do not provide lifetime immunity to COVID or
even prevent you from getting it in the short term. Pfizer is also the company that created the COVID medicine Paxlovid, which cause Biden to get a rebound COVID
right after he supposedly recovered from COVID.
Ingestible Pills are a version of a digital pill
A digital pill is also known as a smart pill or an ingestible sensor. It is a pharmaceutical dosage form that contains an ingestible sensor inside of a pill. The
sensor begins transmitting medical data after it is consumed.
This pill and its other related technology are considered Digital Medicine. The purpose of the sensor is to determine if a person is taking their medicine or they
are not taking their medicine. In other words, is the patient complying with taking their medicine or are they not complying with taking their medicine?
Maintaining good personal hygiene is among the most effective defenses against gastrointestinal and infectious disorders such as the flu, and the common cold.
By using soap and water to wash your hands, you can prevent the spread of germs that can make you sick.
When it comes to your own health, basic personal hygiene can also assist protect you from infecting others. A typical personal hygiene consists of following habits:
Every day, washing your face and body
Washing your hands after using the bathroom with soap
Twice daily cleaning of the teeth
When you sneeze or cough, using a tissue (or your sleeve) to cover your mouth and nose
After touching pets and other animals, cleaning your hands
Here's what you can do to reduce the spread of infection through a basic personal hygiene:
Keeping Food In A Safe Environment
Before and after cooking, wash your hands. Thus, you won't be able to contaminate food and won't get sick or spread bacteria from food, such as raw meat
Endocrinology is the study of hormones and glands in the human body. The endocrine system produces and secretes hormones that regulate many bodily functions,
including growth and development, metabolism, and reproductive health. Endocrinologists are physicians who specialize in diagnosing and treating hormonal imbalances
and disorders. There are several reasons why you might consider seeing an endocrinologist. In this article, we'll explore some of the most common reasons people seek
out the expertise of an endocrinologist.
YOU HAVE DIABETES
If you have diabetes, it is important to consider seeing an endocrinologist. Endocrinologists specialize in managing diabetes and can help you develop a personalized
treatment plan to manage your blood sugar levels. They can also help you prevent or manage complications of diabetes, such as nerve damage, kidney disease, and eye
problems. An endocrinologist can work with you to develop a healthy lifestyle plan that includes diet, exercise, and medication management.
They can also help you adjust your treatment plan as needed to ensure that your diabetes is well-controlled. Seeing an endocrinologist can help you achieve better
health outcomes and improve your overall quality of life.
Recently, the English Health Secretary has talked about introducing a 'Pharmacy First' model similar to that which exists in Scotland. This would be a win-win
outcome providing people with better access to essential healthcare support, advice and treatment whilst relieving strain on other parts of the NHS, not least GPs
and A&E.
It is a no-brainer and yet despite a few media headlines there are still no firm proposals on the table to make this a reality. It surely cannot be right that you
can receive a broad range of patient care services in Scotland which are not available in England. It works well in Scotland, Wales is keen to develop more
pharmacy-based services and Northern Ireland, leaving aside the current funding dispute, has had a minor ailments service for many years.
If the English Health Secretary is sincere in his interest in adopting an English version of the Scottish model, then there are critical aspects he needs to
consider.
Firstly, start with the patient journey through the healthcare ecosystem from illness prevention through to long-term condition management. What is the role of
community pharmacy and how do we guide people to seek support from the most appropriate healthcare professional?
What is the vision for community pharmacy delivering patient care in the next decade?
The lesson from Scotland is that the government needs to sit down with the sector and map that out together. There are no quick fix overnight solutions. This needs
to be a long-term commitment backed by adequate funding. Supervision regulations need to change and there needs to be a thought through workforce strategy which
avoids community pharmacy shortages as that does nothing to deliver improved patient outcomes.
NHS West Yorkshire Integrated Care Board (ICB)'s decision to withdraw gluten free prescriptions for people with coeliac disease across Leeds and Calderdale
has disappointed Coeliac UK.
In a statement released on Thursday, the charity, which provides support and advice to those living with the disease, has raised "grave concerns" about the decision,
warning that it will have a detrimental impact on the coeliac community.
The policy is currently implemented across the ICB's other places including Bradford district and Craven, Kirklees and Wakefield district, preventing coeliac
patients from accessing gluten free bread and flour mix on prescription.
NHS West Yorkshire ICB wants to align its gluten free prescribing guidelines across its five places.
But the charity is worried that the additional cost of gluten free staple products will poses a real challenge to maintaining the gluten-free diet, which is the
only treatment for the condition.
Good news for patients whose epilepsy cannot be controlled by standard anti-seizure drugs! Next month, NHS England will introduce a cutting-edge laser beam
therapy that can prevent seizures in these individuals.
Known as Laser Interstitial Thermal Therapy (LITT), the advanced treatment targets the part of the brain causing seizures without the need for invasive surgery,
the health service said.
The new fibre optic laser therapy is being offered at King's College Hospital in London and The Walton Centre in Liverpool. Starting from June, it will be gradually
extended to eligible patients across England.
Each year, it is expected to benefit up to 50 epilepsy patients in England who are resistant to standard anti-seizure medications.
"This groundbreaking new treatment will change the lives of those with severe epilepsy improving quality of life and providing much-needed assurance," said Andrew
Stephenson, Minister of State for Health.
The Department of Health (DoH) in Northern Ireland has published a new Strategic Plan for Community Pharmacy, highlighting the vision and key priorities for
the sector over the next 10 years.
Co-developed by the DoH and Community Pharmacy Northern Ireland (CPNI), the representative body for community pharmacy owners, the plan aims to fully realise the
potential of community pharmacy services to support better health outcomes from medicines and prevent illness.
The vision outlined in the plan sees community pharmacies offering more clinical services, leveraging the skills of their teams to provide the public with safe,
convenient, and faster access to care.
According to DOH, the vision will be realised through four major reform programmes focusing on services, legislation, workforce, and digital enablers, alongside
six strategic priorities.
Together, these initiatives are anticipated to transform the role of community pharmacy within the Health and Social Care (HSC).
Health Minister Robin Swann has extended his support to the new Community Pharmacy Strategic Plan, which builds on the previously agreed 3-year community pharmacy
commissioning plan.
The Department of Health and Social Care (DHSC) has finally published its response to the 2022 consultation on hub and spoke dispensing.
Considering the consultation evidence and further discussions, the government has expressed its intention to progress the proposals for enabling hub and spoke models
across different legal entities as soon as possible.
This will be achieved by using the enabling powers outlined in Part 2 of the Medicines and Medical Devices Act 2021 (MMDA) to amend the Medicines Act 1968 and the
HMRs.
Furthermore, the DHSC has decided to proceed with the implementation of the two models of hub and spoke dispensing that it consulted on.
The government response to the consultation reads: "Having considered the responses, the government intend to proceed to implement the necessary changes to medicines
legislation to remove the current restrictions that prevent the hub and spoke dispensing models from operating across different legal entities found in section 10 of
the Medicines Act 1968.
The latest formulation of XGEVA (denosumab) is now available to patients in the UK, offering a more convenient treatment option for bone metastasis.
It is the first product to be authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) via the new International Recognition Procedure (IRP).
Denosumab (XGEVA) is used to prevent serious bone-related complications resulting from bone metastasis in adults and to treat giant cell tumour of bone in both
adults and adolescents.
The medicine was authorised on 29 February 2024 as a 120 mg solution for injection in a prefilled syringe. In contrast to the current vial presentation, this
simplifies the administration process, reducing the volume of liquid injected and lowering the risk of dosing errors.
The product was authorised in 30 days by the MHRA, thanks to the new IRP that facilitated a rapid approval process.
The National Health Service (NHS) is embracing new technology and innovations like artificial intelligence (AI) to reduce the number of missed hospital
appointments and improve waiting times for elective care.
Following a successful pilot in Mid and South Essex NHS Foundation Trust, the health service is set to roll out AI software to 10 more trusts across England in
the coming months.
The software, developed by Deep Medical in collaboration with a frontline worker and NHS clinical fellow, helps reduce the number of missed appointments by
offering patients convenient time slots and backup booking options.
Since the AI programme was piloted six months ago, Mid and South Essex NHS Foundation Trust has seen a 30 per cent fall in non-attendances.
During the pilot period, a total of 377 did not attends (DNAs) were prevented and an additional 1,910 patients were attended.
Labour's Paulette Hamilton has raised concerns regarding the increasing reliance on pharmacy technicians in clinical practice due to staffing shortages
within pharmacies.
At the recent Pharmacy Inquiry session, Hamilton highlighted the mounting pressure on technicians to take on more responsibilities beyond their qualifications,
attributing it to the launch of Pharmacy First in January.
With almost 50,000 Pharmacy First consultations conducted in the first month alone as per a report by the Company Chemists' Association, Hamilton expressed
apprehension about technicians being classified under the broad term of "pharmacy professionals," blurring the distinction between their roles and those of
clinical pharmacists.
She further drew parallels between this situation and the scrutiny faced by physician associates (PAs) in GP practices following a patient's death due to
misdiagnosis and cautioned against technicians performing tasks beyond their expertise and urged policymakers to prevent similar incidents in pharmacy settings.
Health Minister Dame Andrea Leadsom responded by defending the current approach, denying any "blurring of the edges" and emphasizing patient safety as the
top priority.
The UK government has awarded a £1.7 million contract to Ensilicated Technologies Ltd (EnsiliTech), a University of Bath spinout company dedicated to
making vaccines safer, to develop the world's first thermally stable mRNA vaccine.
mRNA vaccines have a huge potential to prevent infectious diseases and a range of previously unpreventable conditions, but currently, these vaccines require
ultracold storage, needing to be kept at -70 or even -80 °C.
The company's ensilication technology allows vaccines and other biological materials to be transported and stored without the use of refrigeration.
Dr Asel Sartbaeva, co-founder and CEO at EnsiliTech, believes that the technology could save tens of thousands of lives every year.
She commented: "We're so proud to have won this important government grant."
QuickBooks Error 6000 301 Tool Hub is a free, centralized suite of utilities designed to diagnose and resolve various problems you might encounter with your QuickBooks Desktop software.Encountering Error 6000 301 in QuickBooks can be frustrating as it prevents you from opening or accessing your company file. However, by understanding the potential causes and available solutions, you can effectively tackle this common issue.
Understanding the Error:
This error usually displays a message like "An error occurred when QuickBooks tried to access the company file. Please try again. If the problem persists, contact Intuit Technical Support and provide them with the following error codes: (-6000, -301)." It indicates an underlying problem preventing QuickBooks from interacting with your company file.
By understanding the potential causes of Error 6000 301 and following these troubleshooting steps, you should be able to resolve the issue and regain access to your QuickBooks company file. Remember, keeping your software updated, maintaining a healthy system, and seeking professional help when needed are crucial for effective troubleshooting.
Part of a raft of National Health Services (NHS) measures which aim to support people to prevent or reduce incidence of type 2 diabetes and obesity, the
NHS Digital Weight Management Programme has emerged as a beacon of success in the battle against obesity, with a recent study showcasing its effectiveness in
aiding weight loss among participants.
According to research published in The Obesity Journal, the programme has garnered significant traction, with over 63,000 individuals referred in its inaugural year.
Encouragingly, half of those referred opted to enroll in the service, highlighting its appeal and accessibility.
Among the 14,000 participants who completed the 12-week programme between April 2021 and March 2022, a notable average weight loss of 3.9kg (equivalent to 8.59lbs)
was achieved.
Even among those who did not complete the programme, an average weight loss of 2.2kg (approximately 4.85lbs) was observed.
The 8th Pharmacy Business Conference, organised by Pharmacy Business, unfolded a dynamic narrative around the theme of 'Pharmacy of Tomorrow', highlighting
the trajectory of innovation, adaptation, and the evolving landscape of pharmaceutical services.
Attended by over 200 pharmacy owners, industry leaders, and stakeholders, the conference served as a medium for robust discussions and the exchange of valuable
insights regarding the future of community pharmacy.
Amidst the persistent challenges posed by an underfunded reimbursement system and negotiations with governmental bodies and the NHS for the new community pharmacy
contractual framework 2024/25, the conference pivoted towards investing in staff, adapting to change by investing in new technology, and optimising commissioning
as pivotal strategies.
"Pharmacy professionals are playing increasingly important clinical roles in both primary and secondary care," shared David Webb, Chief Pharmaceutical Officer
(CPO), NHS in a video message.
He highlighted the NHS's commitment to empowering community pharmacy, with plans to expand services and deprescribe to align with the NHS's focus on preventive
healthcare.
The Scottish government has appointed Christina McKelvie MSP as the new Minister for Drugs and Alcohol policy, following the resignation of Elena
Whitham MSP due to health reasons.
In a letter to the First Minister, Whitham said she was receiving treatment for post-traumatic stress, which had "greatly" affected her wellbeing.
Commenting on the news, Royal Pharmaceutical Society (RPS) Scotland thanked Whitham for supporting them, particularly for her "efforts to bring in a new
national service to provide emergency access to supplies of naloxone."
RPS Scotland has continuously advocated for the accessibility of naloxone through all community pharmacies (for supply to people who use drugs, family, healthcare
professionals and carers), and to make it available in all clinical settings for use in emergencies.
It was also the top recommendation of their policy on Pharmacy's role in reducing harm and preventing drug deaths.
Achieving and maintaining healthy-looking skin is a journey that requires dedication and a well-rounded approach. Our skin, the largest organ in our body,
deserves the utmost care to thrive. In this comprehensive guide, we will delve into a step-by-step approach that encompasses various aspects of skincare,
from daily routines to advanced treatments. Discover the secrets to a radiant complexion that not only looks good but also reflects your overall well-being.
Establish a Consistent Daily Routine
A consistent daily skincare routine is the bedrock for achieving and maintaining healthy skin. This foundational step involves a series of carefully chosen
products and practices that work together to nourish, protect, and rejuvenate your skin. Begin your routine with a gentle cleanser to remove impurities and prepare
your skin for subsequent products. Follow this with a balancing toner to restore your skin's pH and create an optimal environment for absorption. Integrate a
quality moisturizer to keep your skin hydrated and maintain its natural barrier. Don't overlook the importance of sunscreen in the morning to shield your skin
from the harmful effects of UV rays. This daily ritual not only provides essential nutrients for your skin but also establishes a preventive measure against
environmental stressors, setting the stage for a radiant and healthy complexion.
Prime Minister Rishi Sunak, during today's (15th May ) Prime Minister's Questions (PMQs), reiterated his commitment to supporting community pharmacies amidst
growing concerns over pharmacy closures.
Addressing questions regarding the Pharmacy First initiative, Sunak assured the House of Commons of his dedication to bolstering resources for these vital healthcare
providers.
In response to a query raised by Member of Parliament, St Ives MP Derek Thomas, citing statistics from the National Pharmacy Association (NPA) about "committing to
directing funds towards Community Pharmacy to alleviate financial pressure and prevent closures, Sunak remarked that he "cares deeply about the future of community
pharmacies."
Sunak acknowledged the indispensable role played by community pharmacists in alleviating pressure on urgent care services, emphasising the importance of initiatives
like Pharmacy First in government's commitment to supporting community pharmacies.
"There are over 10 and a half Community pharmacies across the country working incredibly hard to serve their patients," Sunak said praising the community pharmacists
and highlighted the concerning trend of pharmacy closures, citing a significant increase compared to the previous year.
